Insulet (Nasdaq:PODD) announced on social media today that it appointed a new SVP, chief quality, regulatory and compliance officer. The company picked medical device industry veteran Chuck Medovich to take on the role. Medovich brings more than 30 years of experience across quality, regulatory, manufacturing and R&D functions. His track record includes more than two […]
Personnel
Insulet picks longtime Stryker leader as new chief commercial officer
Insulet (Nasdaq:PODD) announced today that it appointed Mike Panos as EVP, chief commercial officer (CCO), effective immediately. In this role, Panos takes responsibility for the Acton, Massachusetts-based automated insulin delivery system developer’s global commercial organization. He reports to President and CEO Ashley McEvoy and serves on the executive leadership team. Panos brings 30 years of […]
Kevin Sayer returns from leave of absence to chair Dexcom board
Dexcom (Nasdaq:DXCM) announced today in an SEC filing that former CEO Kevin Sayer has returned from his leave of absence. Sayer notified the San Diego-based continuous glucose monitor (CGM) maker of his plan to return on Feb. 27, 2026. His return went into effect today, March 2, 2026, according to the filing. Upon his return, […]
Dexcom adds Google exec to its board
Dexcom (Nasdaq:DXCM) announced that it appointed Rick Osterloh to its board of directors, effective Feb. 26, 2026. Osterloh currently serves as SVP, Platforms and Devices at Google. There, he leads a unified group spanning the tech giant’s portfolio of advanced consumer technologies. San Diego-based Dexcom said in a news release that Osterloh offers significant experience […]
Ascensia Diabetes Care has a new CEO
Ascensia Diabetes Care, a PHC Holdings subsidiary, today announced the appointment of Peter Bodlund as president and CEO. Bodlund succeeds Koichiro Sato, effective April 1, 2026. Sato continues in his roles as COO of the PHC Group and head of PHC Group’s Diabetes Management business. An experienced leader across global healthcare and life sciences organizations, […]
Dexcom CEO Jake Leach named chair of AdvaMed Diabetes Sector
AdvaMed announced today that it named Dexcom President and CEO Jake Leach as the new chair for the AdvaMed Diabetes Sector. Leach succeeds Abbott EVP of Diabetes Care, Chris Scoggins, in the position. Eric Benjamin, Insulet’s EVP and COO, will serve as the vice chair for the medical device industry association’s Diabetes Sector, which represents […]
Embecta names CEO Kurdikar as new board chair, picks new lead independent director
Embecta (Nasdaq:EMBC) announced today that its board of directors elected the company’s CEO, Devdatt “Dev” Kurdikar, as chair. The Parsippany, New Jersey-based BD Diabetes spinoff also named Dr. Claire Pomeroy as lead independent director. Both appointments go into effect immediately. These changes follow the retirement of David Melcher, who previously served as non-executive chair of the […]
LifeScan CEO Valerie Asbury retires from glucose management company
LifeScan CEO Valerie Asbury said on social media today that she is retiring from the glucose management technology developer. On LinkedIn, Asbury said she plans to step away after more than 15 years at the company. “Today marks my last day at LifeScan, and while it is bittersweet, I am deeply grateful for the remarkable […]
ViCentra picks former Insulet leader as VP, global marketing
Insulin patch pump maker ViCentra announced today that it appointed Reman McDonagh as its VP, global marketing. The Utrecth, the Netherlands-based company said McDonagh’s appointment further strengthens its leadership team as it scales commercial execution across Europe. It also bolsters the company amid preparations for its next-generation Kaleido system, including expected European and U.S. launches. McDonagh’s […]
Insulet appoints first chief corporate affairs officer
Insulet (Nasdaq:PODD) announced today that it appointed Cristal Downing as its new chief corporate affairs officer, effective today. In the newly created role at the automated insulin delivery system developer, Downing will build and lead a corporate affairs function aimed at strengthening Insulet’s corporate reputation, advancing business priorities, catalyzing customer value and deepening engagement with […]
